Cleveland Clinic London Cancer Centre will expand an 81,000-square-foot at 40 Grosvenor Place in Belgravia, London, to provide medical oncology and haematology care, as well as systemic cancer therapies such as immunotherapy, chemotherapy, targeted therapies, and radiotherapy.
Construction is scheduled to commence in the fourth quarter of 2025, with completion expected by the end of 2027.
The Cleveland Clinic London Cancer Centre site, which offers one of the most extensive cancer programs in the UK Independent market, will provide the most advanced treatments. Multidisciplinary cancer care will comprise surgical oncology, medical oncology, and haematology, as well as systemic cancer medicines like immunotherapy, chemotherapy, targeted therapies, and radiotherapy that are personalised to each patient. In addition to cancer care, Cleveland Clinic London wants to expand its clinical offerings in the future.
“Our mission is rooted in providing patients with the highest quality care, wherever they live,†said Tom Mihaljevic, M.D., Cleveland Clinic CEO and President and holder of the Morton L. Mandel CEO Chair. “By expanding our services in London, we are addressing the growing demand for advanced cancer care and meeting the needs of patients closer to home.â€
According to Cancer Research UK, over 375,000 new cancer cases are diagnosed each year in the UK, and this figure is likely to climb as the population ages. The most common cancers diagnosed are breast, lung, prostate, and colorectal cancer.
Cleveland Clinic’s foreign sites provide comprehensive cancer care and cutting-edge treatments, backed up by breakthrough basic, clinical, and translational research. The health system’s worldwide cancer team consists of over 800 physicians, researchers, nurses, and technicians who care for thousands of patients each year and offer access to a variety of clinical trials. Consultants at Cleveland Clinic London Cancer Centre will work closely with colleagues from the Cleveland Clinic’s renowned cancer programs in the United States and Abu Dhabi to provide multidisciplinary care, precision medicine, research, and the most advanced cancer medicines to patients in the United Kingdom.
“Our vision is for anyone diagnosed with cancer to have access to the most advanced care in a way that is accessible for them and now we are bringing that to London,†says Alex A. Adjei, M.D., Ph.D., chief of Cleveland Clinic Cancer Institute. “Our focus is on delivering the most effective treatments to achieve long-term survival and improve patients’ quality of life.â€
Cleveland Clinic is dedicated to expanding access to clinical trials, creating novel therapeutics, and focussing on underserved areas of study, such as understanding the causes and management of cancer treatment side effects, as well as preventing and treating young-onset cancer.
Cleveland Clinic London Cancer Centre now provides modern surgical treatment for a variety of cancers, with a multidisciplinary team to personalise each patient’s care and cutting-edge imaging technology such as MRI, CT, and ultrasound scanners. Cancer-related offerings currently include treatment for adrenal, thyroid, head and neck, colorectal, liver, oesophageal, pancreatic, peritoneal, stomach, gynaecologic, lung, sarcoma, brain and spinal tumours, and urologic cancer.
